Schank, T. E., Forschner, A., Sachse, M. M., Dimitrakopoulou-Strauss, A., Sachpekidis, C., Stenzinger, A., . . . Hassel, J. C. (2021). Complete metabolic response in FDG-PET-CT scan before discontinuation of immune checkpoint inhibitors correlates with long progression-free survival. Cancers, 13(11), . https://doi.org/10.3390/cancers13112616
Chicago-Zitierstil (17. Ausg.)Schank, Timo Emanuel, Andrea Forschner, Michael Max Sachse, Antonia Dimitrakopoulou-Strauss, Christos Sachpekidis, Albrecht Stenzinger, Anna-Lena Volckmar, Alexander Enk, und Jessica C. Hassel. "Complete Metabolic Response in FDG-PET-CT Scan Before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-free Survival." Cancers 13, no. 11 (2021). https://doi.org/10.3390/cancers13112616.
MLA-Zitierstil (9. Ausg.)Schank, Timo Emanuel, et al. "Complete Metabolic Response in FDG-PET-CT Scan Before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-free Survival." Cancers, vol. 13, no. 11, 2021, https://doi.org/10.3390/cancers13112616.